Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Malignant Lymphoma

  Free Subscription


05.06.2023

1 Am J Clin Pathol
1 Am J Surg Pathol
5 Blood
2 BMC Cancer
1 BMC Neurol
1 Curr Treat Options Oncol
2 Haematologica
1 Hum Pathol
1 J Am Acad Dermatol
1 Leuk Lymphoma
1 Mod Pathol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. XIAO W, Amador C, Cook JR, Czader M, et al
    B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH/EAHP Workshop.
    Am J Clin Pathol. 2023;159:522-537.
    PubMed         Abstract available


    Am J Surg Pathol

  2. SATOU A, Takahara T, Yamashita D, Seki M, et al
    Diagnostic Utility of STAT6 and pSTAT6 Immunohistochemistry for Distinguishing Classic Hodgkin Lymphoma and Peripheral T-Cell Lymphoma With Hodgkin and Reed-Sternberg-like Cells.
    Am J Surg Pathol. 2023 May 30. doi: 10.1097/PAS.0000000000002062.
    PubMed         Abstract available


    Blood

  3. LUGTENBURG PJ, Mutsaers PGNJ
    How I treat older patients with DLBCL in the frontline setting.
    Blood. 2023;141:2566-2575.
    PubMed         Abstract available

  4. SACCO A, Desantis V, Celay J, Giustini V, et al
    Targeting the immune microenvironment in Waldenstrom macroglobulinemia via halting the CD40/CD40-ligand axis.
    Blood. 2023;141:2615-2628.
    PubMed         Abstract available

  5. MEI M, Herrera AF
    The next frontier: enter PD-1 and exit PET scans?
    Blood. 2023;141:2545-2546.
    PubMed        

  6. KURUVILLA J
    Targeted therapy in mediastinal gray zone lymphoma.
    Blood. 2023;141:2673-2674.
    PubMed        

  7. SLOAN SL, Brown F, Long ME, Weigel C, et al
    PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma.
    Blood. 2023 Jun 2:blood.2022019419. doi: 10.1182/blood.2022019419.
    PubMed         Abstract available


    BMC Cancer

  8. OH BC, Cho AR, Nam JH, Yang SY, et al
    Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements.
    BMC Cancer. 2023;23:482.
    PubMed         Abstract available

  9. WU J, Guo Q, Zhu J, Wu Y, et al
    Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence.
    BMC Cancer. 2023;23:485.
    PubMed         Abstract available


    BMC Neurol

  10. CHEN D, Zhou J, Lu W, Lu L, et al
    Lymphomatoid granulomatosis with the central nervous system involvement as the main manifestation: a case report.
    BMC Neurol. 2023;23:208.
    PubMed         Abstract available


    Curr Treat Options Oncol

  11. WU S, Blombery P, Westerman D, Tam CS, et al
    Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma.
    Curr Treat Options Oncol. 2023 May 30. doi: 10.1007/s11864-023-01102.
    PubMed         Abstract available


    Haematologica

  12. CROMBIE JL, Jacobson CA, Redd R, Shouse G, et al
    Prognostic value of early PET in patients with large B-cell lymphoma treated with anti-CD19 CAR T-cell therapy.
    Haematologica. 2023 Jun 1. doi: 10.3324/haematol.2022.282345.
    PubMed         Abstract available

  13. SAVAGE KJ, Slack GW
    DUSP22-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome.
    Haematologica. 2023;108:1463-1467.
    PubMed        


    Hum Pathol

  14. UCCELLA S, Goteri G, Maiorana A, Donati V, et al
    Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas.
    Hum Pathol. 2023;136:44-55.
    PubMed         Abstract available


    J Am Acad Dermatol

  15. ARCURI D, Kaouache M, Lagace F, Sasseville D, et al
    Research Letter: A Case-Control Pharmacovigilance Study of TNF-Alpha Inhibitors and Interleukin Inhibitors on Tuberculosis, Candida, Lymphoma and Suicidality Using the FAERS Database (2014-2020).
    J Am Acad Dermatol. 2023 May 26:S0190-9622(23)00980.
    PubMed        


    Leuk Lymphoma

  16. SALIM R, Husby S, Winther Eskelund C, Scott DW, et al
    Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score.
    Leuk Lymphoma. 2023 Jun 1:1-10. doi: 10.1080/10428194.2023.2216819.
    PubMed         Abstract available


    Mod Pathol

  17. HAN B, Yim J, Lim S, Na S, et al
    Prognostic Impact of the Immunoscore Based on Whole-Slide Image Analysis of CD3+ Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma.
    Mod Pathol. 2023 May 29:100224. doi: 10.1016/j.modpat.2023.100224.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: